Drug Shortage Report for 0.9% SODIUM CHLORIDE INJECTION USP

Last updated on 2022-06-03 History
Report ID 142809
Drug Identification Number 02304341
Brand name SODIUM CHLORIDE INJECTION USP 0.9%
Common or Proper name Sodium Chloride Injection USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SODIUM CHLORIDE
Strength(s) 9MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 mL
ATC code V07AB
ATC description ALL OTHER NON-THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-20
Estimated end date 2022-07-08
Actual end date
Shortage status Actual shortage
Updated date 2022-06-03
Company comments Inventory released to market in May and June. Product will remain on allocation until resupply.
Health Canada comments
Tier 3 Status Yes
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-06-03 French Compare
v13 2022-06-03 English Compare
v12 2022-04-14 French Compare
v11 2022-04-14 English Compare
v10 2022-03-14 French Compare
v9 2022-03-14 English Compare
v8 2022-02-22 French Compare
v7 2022-02-22 English Compare
v6 2022-01-21 English Compare
v5 2022-01-04 French Compare
v4 2022-01-04 English Compare
v3 2021-07-21 English Compare
v2 2021-07-20 French Compare
v1 2021-07-20 English Compare

Showing 1 to 14 of 14